MIR6129

Across TCGA pan-cancer cohorts, MIR6129 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR6129 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR6129 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6129 expression acts as an unfavorable survival marker, although some lineages such as BLCA and CESC show a favorable association.

LUAD, KIRC, and BLCA are the cancer types where MIR6129 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.291	0.544	.009	54	view →
KIRC	DFS	Tertile	II,III,IV	0.234	0.562	.002	52	view →
BLCA	OS	Tertile	All	0.700	0.574	.008	30	view →
KIRP	DFS	Tertile	All	0.839	0.939	.006	26	view →
OV	DFS	Quartile	IV	0.287	0.528	.006	18	view →
TGCT	OS	Tertile	All	0.925	0.991	.020	12	view →
CESC	OS	Tertile	All	0.736	0.515	.020	10	view →
STAD	DFS	Tertile	IV	0.520	0.250	.033	9	view →
CHOL	OS	Tertile	III,IV	1.000	0.361	.031	7	view →
LIHC	OS	Quartile	III,IV	0.206	0.617	.010	7	view →
DLBC	DFS	Median	III,IV	1.000	0.146	.017	6	view →
LGG	DFS	Quartile	All	0.755	0.852	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR6129–LUAD (OS)

Open the LUAD breakdown →